Epstein-Barr/MS Link; How CBD Curtails Seizures; NIH Finds Rare Neurologic Disease

— News and commentary from the world of neurology and neuroscience

MedicalToday
Neuro Break over a computer rendering of neurons.

Mounting evidence supports a pivotal role of (MS), creating opportunities for MS prevention and therapy. (Lancet Neurology)

Non-ictal allodynia predicted anti-calcitonin gene-related peptide in migraine patients. (Cephalalgia)

Cannabidiol (CBD), approved in a purified form (Epidiolex) to treat rare epilepsy disorders, may reduce seizures by blocking the synaptic effects of lysophosphatidylinositol and dampening a , a mouse study suggested. (Neuron)

Lower educational quality during childhood was tied to in later life. (JAMA Neurology)

Young children have between regions that process cognitive demand and language similar to adults, functional MRIs showed. (Journal of Neuroscience)

Data from about 450 lines of suggested that cell composition and patient sex are significant sources of variation in amyotrophic lateral sclerosis that should be controlled for in future research. (Neuron)

A functional MRI technique complemented self-reported data to in law. (Science Advances)

Variation in cognitive functioning as variation over the next 30 years. (PLoS ONE)

Investigational leriglitazone failed to meet its primary efficacy endpoint in the ADVANCE trial of but secondary findings suggested the drug might have benefit. (Lancet Neurology)

NIH identified three children from two unrelated families with a associated with mutations in both copies of the ATG4D gene. (npj Genomic Medicine)

  • Judy George covers neurology and neuroscience news for , writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.